This activity is deigned for physicians, nurses, nurse practitioners and other healthcare professionals and aims to enhance patient care by incorporating the latest evidence-based practices and ensuring consistent care among providers. It focuses on the appropriate management of thrombotic microagniopathy, hemolytic anemia, as well as platelet and bleeding disorders. 

Additionally, the program provides a forum for discussing complex hematological cases without expert consensus, improving long term outcomes of patients with sickle cell disease, iTTP, hemophilia, von willebrand disease, HHT, ITP and porphyria.

Course Director:

• Gaurav Shah, MD  

Overall Objectives:

1. Incorporate the latest evidence-based practice and ensure consistent care amongst providers 
2. Distinguish appropriate tapering of therapeutic plasma exchange and steroid use
3. Evaluate when to order bone marrow biopsy, send out testing, and evaluate for secondary courses

Target Audience:  
This activity is designed for physicians, pharmacy, nursing, and other healthcare professionals.

Accreditation Statement

In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Statement(s)

American Medical Association (AMA) 
Advocate Health designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.